The simplicity of Merck's monoclonal antibody for RSV in infants could be a plus in its competition with AstraZeneca's ...

Republicans have faced pushback for their plans to pay for Trump’s tax cuts by reducing federal Medicaid funding and by ...

Several hundred NIH employees signed on to a letter rebuking agency actions since the start of President Trump's second term ...

Health secretary Robert F. Kennedy Jr. has taken the extraordinary step of firing the expert panel that advises the CDC.

A new agreement between the FDA and Avidity Biosciences could further assuage industry concerns about the agency’s stance on ...

The Trump administration’s gutting of global aid is threatening to collapse a network of laboratories responsible for global ...

The Trump executive order is not a pathway to a “gold standard” — it is a blueprint for politicizing science and ...

National Resilience, a startup that has raised over $2 billion by promising to transform drug manufacturing, said it would ...

Four members of the ACIP, which advises the CDC on vaccination policy, have had their status as special government employees ...

The NIH has rescinded a policy requiring recipients of new grants to certify they do not have unlawful DEI programs or ...

Metsera’s obesity drug candidate targeting the amylin hormone showed marked efficacy in an early trial, the company said ...

Metsera, the obesity-focused biotech, said this morning that its drug candidate targeting the amylin hormone showed marked ...